Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unique Quadruple Regimen for H. pylori
NCT03491995Phase 3Unknown
- Start
- Apr 2018
- Primary completion
- Apr 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of moxifloxacin, nitazoxanide, doxycycline in Helicobacter pylori infection. Status: unknown.
02
Drugs
moxifloxacinnitazoxanidedoxycycline
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03491995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03491995.